Daniel Ajona

4.3k total citations · 1 hit paper
56 papers, 2.9k citations indexed

About

Daniel Ajona is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Daniel Ajona has authored 56 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Immunology, 22 papers in Oncology and 17 papers in Molecular Biology. Recurrent topics in Daniel Ajona's work include Complement system in diseases (22 papers), Immunotherapy and Immune Responses (12 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Daniel Ajona is often cited by papers focused on Complement system in diseases (22 papers), Immunotherapy and Immune Responses (12 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Daniel Ajona collaborates with scholars based in Spain, United States and United Kingdom. Daniel Ajona's co-authors include Rubén Pı́o, Luis M. Montuenga, Sergio Ortiz‐Espinosa, John D. Lambris, Leticia Corrales, María J. Pajares, Fernando Lecanda, Ignacio Melero, Javier J. Zulueta and Pierre P. Massion and has published in prestigious journals such as The Journal of Cell Biology, Blood and The Journal of Immunology.

In The Last Decade

Daniel Ajona

49 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges

2018 357 citations Luis Seijó, Daniel Ajona et al. Journal of Thoracic Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Ajona Spain	27	1.5k	944	913	566	417	56	2.9k
Gheath Alatrash United States	24	1.3k 0.9×	1.8k 1.9×	674 0.7×	385 0.7×	232 0.6×	126	2.9k
Sapna P. Patel United States	29	1.2k 0.8×	1.8k 1.9×	1.5k 1.6×	473 0.8×	152 0.4×	210	3.6k
Shigehisa Kitano Japan	31	1.6k 1.1×	2.3k 2.5×	719 0.8×	640 1.1×	226 0.5×	157	3.4k
Maria Vincenza Carriero Italy	34	951 0.6×	1.3k 1.4×	1.5k 1.6×	370 0.7×	324 0.8×	76	3.8k
Frédéric Di Fiore France	32	945 0.6×	2.1k 2.2×	1.4k 1.5×	735 1.3×	363 0.9×	122	4.0k
Wijnand Helfrich Netherlands	38	1.4k 0.9×	1.2k 1.3×	1.7k 1.8×	389 0.7×	998 2.4×	114	3.7k
Maarten L. Janmaat Netherlands	17	567 0.4×	1.3k 1.3×	1.0k 1.1×	525 0.9×	726 1.7×	28	2.4k
Anna Maria Orengo Italy	29	2.3k 1.6×	1.0k 1.1×	754 0.8×	236 0.4×	144 0.3×	63	3.5k
Valérie Gouilleux‐Gruart France	28	1.2k 0.8×	1.4k 1.4×	1.0k 1.1×	200 0.4×	472 1.1×	82	3.0k
Samia Mourah France	33	582 0.4×	1.3k 1.3×	1.5k 1.6×	280 0.5×	183 0.4×	162	3.1k

Countries citing papers authored by Daniel Ajona

Since Specialization

Citations

This map shows the geographic impact of Daniel Ajona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Ajona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Ajona more than expected).

Fields of papers citing papers by Daniel Ajona

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Ajona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Ajona. The network helps show where Daniel Ajona may publish in the future.

Co-authorship network of co-authors of Daniel Ajona

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Ajona. A scholar is included among the top collaborators of Daniel Ajona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Ajona. Daniel Ajona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ajona, Daniel, et al.. (2025). Opposing effects of animal models of type 1 and type 2 diabetes on factor D expression and systemic alternative pathway activity. Immunobiology. 230(4). 153077–153077.

Ajona, Daniel, et al.. (2025). Insights and perspectives into the discovery of complement-related biomarkers in cancer. Current Opinion in Immunology. 96. 102633–102633. 1 indexed citations

Pı́o, Rubén, Yaiza Senent, Beatriz Tavira, & Daniel Ajona. (2024). Fasting and fasting-mimicking conditions in the cancer immunotherapy era. Journal of Physiology and Biochemistry. 81(2). 383–389. 3 indexed citations

Senent, Yaiza, Ana Remírez, Diana Llópiz, et al.. (2024). The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response. Cancer Immunology Research. 13(3). 384–399. 6 indexed citations

Ajona, Daniel, Mark S. Cragg, & Rubén Pı́o. (2024). The complement system in clinical oncology: Applications, limitations and challenges. Seminars in Immunology. 77. 101921–101921. 12 indexed citations

Rodríguez‐Remírez, María, Inés López, María Collantes, et al.. (2023). A novel [89Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer. Frontiers in Immunology. 14. 1272570–1272570. 1 indexed citations

Senent, Yaiza, Beatriz Tavira, Rubén Pı́o, & Daniel Ajona. (2022). The complement system as a regulator of tumor-promoting activities mediated by myeloid-derived suppressor cells. Cancer Letters. 549. 215900–215900. 19 indexed citations

Ajona, Daniel, Luis Seijó, Julián Sanz‐Ortega, et al.. (2021). Molecular biomarkers in early stage lung cancer. Translational Lung Cancer Research. 10(2). 1165–1185. 35 indexed citations

Moreno, Laura, Cristina Pérez, Aintzane Zabaleta, et al.. (2019). The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma. Clinical Cancer Research. 25(10). 3176–3187. 148 indexed citations

10.

Pı́o, Rubén, Daniel Ajona, Sergio Ortiz‐Espinosa, Alberto Mantovani, & John D. Lambris. (2019). Complementing the Cancer-Immunity Cycle. Frontiers in Immunology. 10. 774–774. 159 indexed citations

11.

Ajona, Daniel, Carolina Zandueta, Leticia Corrales, et al.. (2018). Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects. American Journal of Respiratory and Critical Care Medicine. 197(9). 1164–1176. 72 indexed citations

12.

Ajona, Daniel, Sergio Ortiz‐Espinosa, Haritz Moreno, et al.. (2017). A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis. Cancer Discovery. 7(7). 694–703. 187 indexed citations

13.

Jelı́nek, Tomáš, Aintzane Zabaleta, Cristina Pérez, et al.. (2017). Pre-Clinical Efficacy of the Anti-CD38 Monoclonal Antibody (mAb) Isatuximab in Acute Myeloid Leukemia (AML). Blood. 130. 2655–2655. 3 indexed citations

14.

Ajona, Daniel, et al.. (2017). MA09.01 Dual Blockade of PD-1 and C5a/C5aR Synergistically Protects against Non-Small Cell Lung Cancer Tumor Growth. Journal of Thoracic Oncology. 12(1). S391–S391. 1 indexed citations

15.

Ajona, Daniel, Sergio Ortiz‐Espinosa, & Rubén Pı́o. (2017). Complement anaphylatoxins C3a and C5a: Emerging roles in cancer progression and treatment. Seminars in Cell and Developmental Biology. 85. 153–163. 110 indexed citations

16.

Miguel, Fernando J. de, María J. Pajares, Elena Martínez‐Terroba, et al.. (2016). A large‐scale analysis of alternative splicing reveals a key role of QKI in lung cancer. Molecular Oncology. 10(9). 1437–1449. 56 indexed citations

17.

Pı́o, Rubén, Leticia Corrales, Daniel Ajona, et al.. (2010). Complement Factor H Is Elevated in Bronchoalveolar Lavage Fluid and Sputum from Patients with Lung Cancer. Cancer Epidemiology Biomarkers & Prevention. 19(10). 2665–2672. 27 indexed citations

18.

Ajona, Daniel, Leticia Corrales, José M. López-Picazo, et al.. (2010). Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo. Molecular Cancer. 9(1). 139–139. 73 indexed citations

19.

Ajona, Daniel, et al.. (2007). Down-Regulation of Human Complement Factor H Sensitizes Non-Small Cell Lung Cancer Cells to Complement Attack and Reduces In Vivo Tumor Growth. The Journal of Immunology. 178(9). 5991–5998. 86 indexed citations

20.

Okrój, Marcin, et al.. (2007). Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactors. Molecular Immunology. 45(1). 169–179. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact